We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Interactive Motivational Media for Perinatal Drug Abuse - 3

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00230048
First Posted: September 30, 2005
Last Update Posted: October 31, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Steven J. Ondersma, Wayne State University
Results First Submitted: October 12, 2011  
Study Type: Interventional
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Single (Outcomes Assessor);   Primary Purpose: Treatment
Condition: Substance-Related Disorders
Intervention: Behavioral: Brief computer-delivered intervention

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Assessment Only This arm answered questions only, but received no intervention.
Brief Intervention Brief computer-delivered intervention following motivational approach, adapted from Motivational Interviewing: Decisional balance, normed feedback, and optional goal-setting.

Participant Flow:   Overall Study
    Assessment Only   Brief Intervention
STARTED   52   55 
Completed Intervention/Control Session   52   55 
COMPLETED   39   37 
NOT COMPLETED   13   18 
Lost to Follow-up                13                18 



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Assessment Only This arm answered questions only, but received no intervention.
Brief Intervention Brief computer-delivered intervention following 5As/5Rs approach.
Total Total of all reporting groups

Baseline Measures
   Assessment Only   Brief Intervention   Total 
Overall Participants Analyzed 
[Units: Participants]
 52   55   107 
Age 
[Units: Participants]
     
<=18 years   0   0   0 
Between 18 and 65 years   52   55   107 
>=65 years   0   0   0 
Age 
[Units: Years]
Mean (Standard Deviation)
 24.2  (5.4)   25.9  (5.7)   25.1  (5.6) 
Gender 
[Units: Participants]
     
Female   52   55   107 
Male   0   0   0 
Region of Enrollment 
[Units: Participants]
     
United States   52   55   107 


  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Number of Participants With Drug Use at 3 Months   [ Time Frame: 3 months ]

2.  Primary:   Treatment Engagement   [ Time Frame: 3 months ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
Generalizability limited by relatively small sample, attrition of 29%, and restriction to low-income mothers. Second, power limitations prevented verification of effects on the dichotomous outcomes, despite effects in the small-moderate range.


  More Information
  Hide More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.


Results Point of Contact:  
Name/Title: Steven J. Ondersma
Organization: Wayne State University
phone: 313-577-6680
e-mail: s.ondersma@wayne.edu


Publications of Results:

Responsible Party: Steven J. Ondersma, Wayne State University
ClinicalTrials.gov Identifier: NCT00230048     History of Changes
Other Study ID Numbers: NIDA-14621-3
R21DA014621 ( U.S. NIH Grant/Contract )
First Submitted: September 29, 2005
First Posted: September 30, 2005
Results First Submitted: October 12, 2011
Results First Posted: August 16, 2012
Last Update Posted: October 31, 2012